RIAM, an Ena/VASP and Profilin Ligand, Interacts with Rap1-GTP and Mediates Rap1-Induced Adhesion
Esther M. Lafuente(Universidad Complutense de Madrid), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Christopher V. Carman(Emulate (United States)), Alla Berezovskaya(Ontario Institute for Cancer Research), André A. F. L. van Puijenbroek(Harvard University), Frank B. Gertler(Massachusetts Institute of Technology), Erica Constantine(Dana-Farber Cancer Institute), Gordon J. Freeman(Dana-Farber Cancer Institute), Matthias Krause(University of Mannheim), Timothy A. Springer(Harvard University)
Cited by 13
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k